FDA Announces Joint Meeting of Risk Communication and Tobacco Advisory Committees

Summary

The US Food and Drug Administration (FDA) has scheduled a joint meeting of the Risk Communication Advisory Committee and the Tobacco Products Scientific Advisory Committee to discuss tobacco-related issues